These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 6601060

  • 1. Efficacy of human hyperimmune globulin in prevention of Haemophilus influenzae type b disease in infant rats.
    Ambrosino D, Schreiber JR, Daum RS, Siber GR.
    Infect Immun; 1983 Feb; 39(2):709-14. PubMed ID: 6601060
    [Abstract] [Full Text] [Related]

  • 2. Prevention of Haemophilus influenzae type b infections in high-risk infants treated with bacterial polysaccharide immune globulin.
    Santosham M, Reid R, Ambrosino DM, Wolff MC, Almeido-Hill J, Priehs C, Aspery KM, Garrett S, Croll L, Foster S.
    N Engl J Med; 1987 Oct 08; 317(15):923-9. PubMed ID: 2442610
    [Abstract] [Full Text] [Related]

  • 3. Passive immunization against disease due to Haemophilus influenzae type b: concentrations of antibody to capsular polysaccharide in high-risk children.
    Ambrosino DM, Landesman SH, Gorham CC, Siber GR.
    J Infect Dis; 1986 Jan 08; 153(1):1-7. PubMed ID: 3484503
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Anticapsular antibody requirements for protection against experimental Haemophilus influenzae type b bacteremia after splenectomy.
    Rubin LG.
    Infect Immun; 1988 Apr 08; 56(4):984-6. PubMed ID: 3257941
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of Haemophilus influenzae type b and pneumococcal disease.
    Siber GR, Thompson C, Reid GR, Almeido-Hill J, Zacher B, Wolff M, Santosham M.
    J Infect Dis; 1992 Jun 08; 165 Suppl 1():S129-33. PubMed ID: 1588146
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of the protective efficacy of Haemophilus influenzae type b vaccines in an animal model.
    Halsey NA, Johansen TL, Bowman LC, Glode MP.
    Infect Immun; 1983 Mar 08; 39(3):1196-200. PubMed ID: 6601621
    [Abstract] [Full Text] [Related]

  • 13. Further studies of the role of noncapsular antibody in protection against experimental Haemophilus influenzae type b bacteremia.
    Shenep JL, Munson RS, Barenkamp SJ, Granoff DM.
    Infect Immun; 1983 Oct 08; 42(1):257-63. PubMed ID: 6604698
    [Abstract] [Full Text] [Related]

  • 14. Decreased protective efficacy of reduced and alkylated human immune serum globulin in experimental infection with Haemophilus influenzae type b.
    Schreiber JR, Barrus VA, Siber GR.
    Infect Immun; 1985 Jan 08; 47(1):142-8. PubMed ID: 3871195
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Preparation of human hyperimmune globulin to Haemophilus influenzae b, Streptococcus pneumoniae, and Neisseria meningitidis.
    Siber GR, Ambrosino DM, McIver J, Ervin TJ, Schiffman G, Sallan S, Grady GF.
    Infect Immun; 1984 Jul 08; 45(1):248-54. PubMed ID: 6429048
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.